Damora Therapeutics, Inc. · NASDAQ:DMRA
Fairmount Funds Management LLC reported a 19.99% stake in Damora Therapeutics, Inc. (Schedule 13D/A)
Event Feb 9, 2026 · Filed Feb 11, 2026
Fairmount Funds Management LLC reported a 19.99% stake in Damora Therapeutics, Inc., 8,713,000 shares, with active intent on Feb 9, 2026. Filed Feb 11, 2026 (Schedule 13D/A).
- Stake
- 19.99%
- Shares
- 8,713,000
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fairmount Funds Management LLC | 19.99% | 8,713,000 |
| Fairmount Healthcare Fund II L.P. | 13.32% | 5,809,000 |
| Fairmount Healthcare Co-Invest V L.P. | 6.66% | 2,904,000 |
| Peter Evan Harwin | 19.99% | 8,713,000 |
| Tomas Kiselak | 19.99% | 8,713,000 |
Source
Related
- Damora Therapeutics, Inc.
- Fairmount Funds Management LLC
- Damora Therapeutics, Inc. shareholders
- Schedule 13D · Fairmount Funds Management LLC · Nov 17, 2025
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026